Clinical and Biochemical Monitoring of Monocarboxylate Transporter 8 Deficiency (Allan-Herndon-Dudley Syndrome) across the Lifespan: Practical Considerations for Multidisciplinary Care
Recommendations
As issued by the authors
Comprehensive, multidisciplinary management strategy for healthcare professionals caring for patients with MCT8 deficiency across all age groups, monitoring key symptoms and sequelae
Individualized patient care plans, given substantial heterogeneity in symptoms and long-term outcomes
Original publication
Clinical and Biochemical Monitoring of Monocarboxylate Transporter 8 Deficiency (Allan-Herndon-Dudley Syndrome) across the Lifespan: Practical Considerations for Multidisciplinary Care. Horm Res Paediatr. Published 2 April 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →